Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8541424 Anti-viral compounds

Patent 8541424 was granted and assigned to Abbott on September, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Abbott

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8541424

Date of Patent

September 24, 2013

Patent Application Number

12644427

Date Filed

December 22, 2009

Patent Citations Received

‌

US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor

‌

US Patent 11866434 Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof

‌

US Patent 11866451 Salts and crystalline forms of a PD-1/PD-L1 inhibitor

‌

US Patent 11873309 Heterocyclic compounds as immunomodulators

‌

US Patent 11673883 Heterocyclic compounds as immunomodulators

‌

US Patent 11753406 Salts of a PD-1/PD-L1 inhibitor

‌

US Patent 11760756 Crystalline form of a PD-1/PD-L1 inhibitor

‌

US Patent 11780836 Process of preparing a PD-1/PD-L1 inhibitor

...

Patent Primary Examiner

‌

Erich A Leeser

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8541424 Anti-viral compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API